Page last updated: 2024-09-05

sibenadet and albuterol

sibenadet has been researched along with albuterol in 4 studies

Compound Research Comparison

Studies (sibenadet)	Trials (sibenadet)	Recent Studies (post-2010) (sibenadet)	Studies (albuterol)	Trials (albuterol)	Recent Studies (post-2010) (albuterol)
27	7	6	10,108	3,059	2,058

Protein Interaction Comparison

Protein	Taxonomy	sibenadet (IC50)	albuterol (IC50)
Beta-2 adrenergic receptor	Homo sapiens (human)		1.2618

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Dixon, J; Fisher, A; Flaherty, A; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A	1
Jackson, D; Jones, B; Lindsey, JK; Stevens, JW	1
Agnew, JE; Dilworth, JP; Hasani, A; Lloyd, J; Toms, N	1

Trials

1 trial(s) available for sibenadet and albuterol

Article	Year
Mucociliary clearance in COPD can be increased by both a D2/beta2 and a standard beta2 agonists. Respiratory medicine, 2005, Volume: 99, Issue:2 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Mucociliary Clearance; Peak Expiratory Flow Rate; Pulmonary Disease, Chronic Obstructive; Quality of Life; Risk Factors; Smoking; Sputum; Thiazoles; Treatment Outcome; Vital Capacity	2005

Article

Year

Mucociliary clearance in COPD can be increased by both a D2/beta2 and a standard beta2 agonists.

Respiratory medicine, 2005, Volume: 99, Issue:2

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Mucociliary Clearance; Peak Expiratory Flow Rate; Pulmonary Disease, Chronic Obstructive; Quality of Life; Risk Factors; Smoking; Sputum; Thiazoles; Treatment Outcome; Vital Capacity

2005

Other Studies

3 other study(ies) available for sibenadet and albuterol

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action. ACS medicinal chemistry letters, 2014, Apr-10, Volume: 5, Issue:4 Topics:	2014
Dynamic modelling of a challenge-escalation cross-over study of treatment of capsaicin-induced coughing. Statistics in medicine, 2002, Oct-30, Volume: 21, Issue:20 Topics: Adrenergic beta-Agonists; Albuterol; Capsaicin; Cough; Cross-Over Studies; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Receptors, Dopamine D2; Thiazoles	2002